NCT02905526 is a NA clinical trial of Contraceptive instant messages in Contraception, sponsored by London School of Hygiene and Tropical Medicine.

Who is sponsoring NCT02905526?

NCT02905526 is sponsored by London School of Hygiene and Tropical Medicine.

What drugs are being tested in NCT02905526?

Interventions in NCT02905526: Contraceptive instant messages, Mobile phone app.

What condition does NCT02905526 study?

NCT02905526 studies Contraception.

Is NCT02905526 still recruiting?

NCT02905526 is currently completed. Last updated 7 February 2018.

Last reviewed 2018-02-07 · How we verify

NCT02905526

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Intervention Delivered by App Instant Messaging to Increase Use of Effective Contraception Among Young Women in Bolivia

Completed NA Last updated 7 February 2018

What this trial tests

NA trial testing Contraceptive instant messages in Contraception in 645 participants. Completed in 31 January 2018.

Timeline

1 March 2017

Primary endpoint
31 January 2018

31 January 2018

Quick facts

Lead sponsor	London School of Hygiene and Tropical Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	645
Start date	1 March 2017
Primary completion	31 January 2018
Estimated completion	31 January 2018
Sites	1 location across Bolivia

Drugs / interventions tested

Contraceptive instant messages
Mobile phone app

Conditions studied

Contraception — all drugs for Contraception →

Sponsor

London School of Hygiene and Tropical Medicine

Who can join

Adults 16 to 24, female only, with Contraception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone app instant messaging on use of effective contraception in Bolivia. Woman aged 16-24 will be randomised to have access to Centro de Investigacion, Educacion y Servicios's sexual and reproductive health app (control) or the app plus 0-3 instant messages a day for 4 months (intervention). Participants will complete a questionnaire at baseline and 4 month follow-up.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

An Intervention Delivered by Mobile Phone Instant Messaging to Increase Acceptability and Use of Effective Contraception Among Young Women in Bolivia: Randomized Controlled Trial.
McCarthy OL, Aliaga C, Torrico Palacios ME, López Gallardo J, et al · · 2020 · cited 12× · PMID 32568092 · DOI 10.2196/14073
An Intervention Delivered by App Instant Messaging to Increase Acceptability and Use of Effective Contraception Among Young Women in Bolivia: Protocol of a Randomized Controlled Trial.
McCarthy OL, Osorio Calderon V, Makleff S, Huaynoca S, et al · · 2017 · cited 10× · PMID 29254910 · DOI 10.2196/resprot.8679
Mobile phone-based interventions for improving contraception use.
Perinpanathan T, Maiya S, van Velthoven MHH, Nguyen AT, et al · · 2023 · cited 6× · PMID 37458240 · DOI 10.1002/14651858.cd011159.pub3

Verify or expand the search:

Other recruiting trials for Contraception

Currently open trials in the same condition.

NCT07365904 — Investigating Ovulation Inhibition for Use as a Contraceptive · Phase 2 · recruiting
NCT07437495 — Women's Knowledge of Contraception During the Postpartum Period · active not recruiting
NCT06823037 — Hormonal Contraception Access Through Pharmacist Prescribing Implementation · NA · recruiting
NCT07326007 — Verbal Analgesia Versus Standard Technique for Pain Control During Copper T380A Intrauterine Device Insertion in Women W · NA · recruiting
NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting

Other London School of Hygiene and Tropical Medicine trials

Trials by the same sponsor.

NCT06921213 — Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis · Phase 2 · not yet recruiting
NCT06923592 — Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar · Phase 3 · recruiting
NCT06833736 — A Health App Using Recipes and Education Components to Facilitate Sustainable and Healthier Diets. · NA · completed
NCT06166498 — Parasite Clearance and Protection From Infection (PCPI) in Zambia · Phase 3 · completed
NCT06173206 — Parasite Clearance and Protection From Infection (PCPI) in Cameroon · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02905526 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by London School of Hygiene and Tropical Medicine
Last refreshed: 7 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02905526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing